Nordic Biomarker
Nordic Biomarker, a leading player in the biotechnology sector, is headquartered in Sweden (SE) and operates extensively across Europe. Founded in 2007, the company has established itself as a key provider of innovative biomarker solutions, focusing on areas such as diagnostics and personalised medicine. With a commitment to advancing healthcare, Nordic Biomarker offers a range of unique products and services, including high-quality biomarker assays and analytical services that cater to both research and clinical applications. The company’s dedication to precision and reliability has positioned it as a trusted partner in the industry, contributing to significant advancements in patient care. Recognised for its expertise, Nordic Biomarker continues to make strides in the field, solidifying its reputation as a pioneer in biomarker development and utilisation.
DitchCarbon Score
How does Nordic Biomarker's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nordic Biomarker's score of 16 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nordic Biomarker's reported carbon emissions
In 2023, Nordic Biomarker reported total carbon emissions of approximately 1,122,000 kg CO2e, with emissions distributed across various scopes: 10,000 kg CO2e from Scope 1, 22,000 kg CO2e from Scope 2, and a significant 1,102,000 kg CO2e from Scope 3. This marks a notable increase in emissions compared to 2022, where total emissions were about 74,000 kg CO2e, comprising 11,630 kg CO2e from Scope 1, 40 kg CO2e from Scope 2, and 61,850 kg CO2e from Scope 3. Despite the increase in emissions, Nordic Biomarker has not disclosed any specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of documented climate pledges or science-based targets suggests a need for enhanced commitment to sustainability practices within the organisation. As a company headquartered in Sweden, Nordic Biomarker operates within an industry increasingly focused on reducing greenhouse gas emissions and addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 11,630 | 00,000 |
| Scope 2 | 40 | 00,000 |
| Scope 3 | 61,850 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nordic Biomarker is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
